Grace Chien
Primary Care · Prescott, AZNPI 1164262143
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AbbVie at 26.5% of the total.
Across 84 payments — averaging $17.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$400
- AstraZeneca$293
- Lilly USA, LLC$236
- Pfizer$175
- Novo Nordisk$107
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$94
- plus $201 from 7 others
What the payments were for
- Food & beverage$1,506100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $400 |
| AstraZeneca | 14 | $293 |
| Lilly USA, LLC | 13 | $236 |
| Pfizer | 10 | $175 |
| Novo Nordisk | 7 | $107 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $94 |
| Amgen | 3 | $48 |
| Exact Sciences | 3 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $34 |
| Dexcom, Inc. | 1 | $21 |
| Aimmune Therapeutics, Inc. | 1 | $19 |
| Abbott | 1 | $17 |
| GSK | 1 | $17 |
How this compares
$1,506 in reported general payments places this provider in the 75th percentile of 151 primary care providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 14 | $357 |
| Atorvastatin Calcium | 23 | $252 |
| Levothyroxine Sodium | 28 | $164 |
| Losartan Potassium | 14 | $134 |
| Metformin Hcl | 18 | $127 |
| Metoprolol Succinate | 17 | $125 |
| Lisinopril | 23 | $92 |
| Amlodipine Besylate | 19 | $52 |
Paid to pharmacies, not to this prescriber.
Other primary care in Prescott
- Reneallia BennettPrescott$4K
- Trey PowrzanasPhoenix$16K
- Christine Rocks-LopezPhoenix$14K
- Elena KlimovaPhoenix$8K
- Albert VillafaniaPhoenix$8K
- Daniela HaimovPhoenix$8K
- Lea NickolasAvondale$7K
- Neena VargheseSacaton$6K
- Katy DodtQueen Creek$5K
- Mercy GeorgeQueen Creek$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.